On a GAAP basis, AbbVie reported quarterly EPS of $0.60, which excludes intangible asset amortization expenses and other items.
The company affirmed its adjusted EPS guidance for the full year of $3.03 to $3.13, which does not include $0.37 per share of items primarily related to costs associated with its separation from Abbott Labs.
The company’s CEO said:
The business generated strong sales growth despite loss of exclusivity in our lipid franchise, which speaks to the foundation of AbbVie’s product portfolio. Additionally, we advanced our promising pipeline during the first quarter, with continued progress across our mid- and late-stage development programs.
AbbVie has now put a stake in the ground and provided investors with some information about the company going forward. Adjusted gross margin totaled 76.2% in the first quarter, and operating profit of $1.31 billion topped the $978 million the company earned in the first quarter of 2012.
The company’s shares are down about 0.1% in premarket trading, at $44.20 in a post-IPO range of $32.51 to $46.32. Thomson Reuters had a consensus analyst price target of around $40.90 before today’s report.
The #1 Thing to Do Before You Claim Social Security (Sponsor)
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
